Market Overview

Reproductive Medicine Experts Launch My Egg Bank North America to Help Women & Couples Struggling to Conceive

Share:
ATLANTA--(BUSINESS WIRE)--

To meet demand from tens of thousands of women and couples trying to conceive, reproductive medicine experts in four cities today launched My Egg Bank North America (MEBNA), the first multi-center network of egg banks. MEBNA offers a more clinically efficient egg freezing technology that is more convenient and less expensive than traditional egg donation — with equal or greater success than older techniques.

Four respected fertility centers – Reproductive Biology Associates in Atlanta, Seattle Reproductive Medicine, Reproductive Science Center of New England in Boston, and the Center for Reproductive Medicine in Orlando – have partnered to form MEBNA to improve access to a proprietary, proven rapid egg freezing technology that can be applied to all aspects of reproductive medicine, including fertility preservation, egg donation and routine in-vitro fertilization.

MEBNA's technology offers incomparable benefits to patients seeking egg donation services, including:

  • Successful outcomes at rates equal to or greater than traditional fresh egg donation;
  • A clinical treatment strategy that delivers the full benefit of services to each patient at one half to one third the cost of traditional fresh egg donation;
  • An immediate start to treatment, avoiding the complex synchronization of donor and recipient menstrual cycles, as well as the need to wait for lengthy donor matches; and,
  • A clinical care model that increases recipient control over donor choice, allowing couples to select from a large number of frozen eggs already in storage immediately at www.MyEggBank.com.

MEBNA has produced more than 550 live births using their rapid egg freezing technology and recently completed its 1000th embryo transfer. MEBNA has produced more live births and transfers using frozen eggs than all other fertility practices in the United States combined.

Due in large part to data generated at RBA and reported by Dr. Zsolt Peter Nagy, Ph.D, the Scientific Director of RBA, and his colleagues in peer-reviewed medical journals, the American Society for Reproductive Medicine recently lifted its experimental designation of egg freezing, declaring that in young patients egg freezing techniques have been shown to produce pregnancy rates, leading to the birth of healthy babies, comparable to IVF cycles using fresh eggs.

“With an estimated 6.7 million women in the U.S. with an impaired ability to have children, and 10,000 patients undergoing egg donation cycles per year, the potential demand for My Egg Bank's rapid egg freezing technology is significant,” said My Egg Bank North America Chief Executive Officer, Ron Davidson. “MEBNA's network model reduces both functional and economic barriers that have historically stood in the way of women and couples seeking egg donation.”

Until now, MEBNA's rapid egg freezing technology, scientifically known as vitrification, was only available to patients of Reproductive Biology Associates (RBA) in Atlanta, where pioneers in reproductive medicine were the first in the country to develop and apply the technology consistently and successfully for hundreds of patients.

“Our proven technology protects donor eggs and freezes them significantly faster, avoiding the cell damage that has hampered success rates in traditional slow-freeze techniques,” said Dr. Zsolt Peter Nagy, Ph.D, the Scientific Director for RBA. “It allows physicians to choose single embryo transfers in more cases, which reduces multiple birth rates and subsequent complications of pregnancy.”

In fertility preservation, MEBNA's technology allows women in their 20's and 30's to delay child bearing by freezing their eggs for future use. This technology also allows for efficient freezing of eggs for women facing fertility-ending medical treatment for cancer and other diseases. It also allows routine IVF patients to store eggs without prior insemination, thus reducing patient concern about the disposition or long-term storage of unused embryos.

“We're excited to be able to expand access to this technology through our partner centers and affiliates,” said Dr. Daniel Shapiro, MD, the Medical Director for MEBNA. “The launch of My Egg Bank North America has the potential to revolutionize reproductive medicine in North America by making the delivery of fertility care more efficient and less costly for women and couples seeking children.”

The four MEBNA partner centers recruit and freeze the eggs of donors that are then listed on the donor data base available at www.MyEggBank.com. These partner centers also use MEBNA's rapid egg freezing technology in both fertility preservation and standard IVF cycles. There are also 18 affiliate IVF centers in the MEBNA network, all of which have been thoroughly trained to maintain the frozen donor cycle success rates that MEBNA has historically achieved.

MEBNA only stores eggs from high quality donors who have passed rigorous medical, genetic and psychological testing. Donors are college educated and come from diverse ethnic and racial backgrounds.

MEBNA's clinical management protocols make donor safety the top priority and virtually eliminate the risk of ovarian hyper-stimulation syndrome. The network's model allows donors to donate at their convenience immediately after completion of the medical, genetic and psychological screening process, avoiding the need for time consuming donor-recipient cycle synchronization.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50452092&lang=en

Solomon McCown & Company, Inc.
Kate Plourd, 617-933-5017
kplourd@solomonmccown.com

View Comments and Join the Discussion!